Cargando…
Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition
Transforming growth factor-β1 (TGF-β1), secreted by main components of tumor microenvironment, is considered to be closely associated with cancer development and chemoresistance. The present study aimed to analyze the effects and mechanisms underlying TGF-β1-induced chemoresistance to oxaliplatin (L...
Autores principales: | Mao, Liang, Li, Yan, Zhao, Jinping, Li, Qia, Yang, Bin, Wang, Yuanyuan, Zhu, Zhitu, Sun, Hongzhi, Zhai, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494727/ https://www.ncbi.nlm.nih.gov/pubmed/28693217 http://dx.doi.org/10.3892/ol.2017.6209 |
Ejemplares similares
-
KIAA1199 promotes oxaliplatin resistance and epithelial mesenchymal transition of colorectal cancer via protein O-GlcNAcylation
por: Hua, Qingling, et al.
Publicado: (2023) -
Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
por: Zhu, Shi Mao, et al.
Publicado: (2019) -
β-catenin, leucine-rich repeat-containing G protein-coupled receptor 5 and GATA-binding factor 6 are associated with the normal mucosa-adenoma-adenocarcinoma sequence of colorectal tumorigenesis
por: Yang, Bin, et al.
Publicado: (2018) -
FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020) -
JunB contributes to Id2 repression and the epithelial–mesenchymal transition in response to transforming growth factor–β
por: Gervasi, Megan, et al.
Publicado: (2012)